Back

Long-term survival outcomes and baseline hemodynamics in patients with PAH versus CTEPH

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in valvular and pulmonary 4 Pulmonary Hypertension HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Joana Mesquita Guimaraes

University Hospitals of Coimbra, Coimbra (Portugal)

3 More presentations in this session

Presentation thumbnail
Exploring the clinical relevance of TSAT <21% as an iron deficiency indicator in pulmonary arterial hypertension: a comparative analysis with alternative criteria and existing guidelines
Doctor N. Ilchyshyn (Almada, PT)
Abstract Slides Video
Presentation thumbnail
Real-world results of selexipag in treating pulmonary hypertension in a portuguese population
Doctor J. Mesquita Guimaraes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
HFWM: exploring biomarkers in chronic thromboembolic pulmonary hypertension (CTEPH): prognostic significance, and post-PEA dynamics analysis
Doctor A. Cuomo (Naples, IT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in valvular and pulmonary 4

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Prognostic value of follow-up hemodynamics after initial treatment in pulmonary arterial hypertension
thumbnail
Congress Presentation
Investigating predictors of mortality in patients with reduced and preserved ejection fraction
thumbnail
Congress Presentation
Different treatments in chronic thromboembolic pulmonary hypertension: comparison of strategies in the Italian centre real-world experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources